MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1158/1078-0432.ccr-24-4120

Медицинская библиотека · Clinical cancer research : an official journal of the American Association for Cancer Research · 2025

Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM.

Yadav Siddhartha, Bao Riyue, Graham Rondell P, Hu Chunling, Hart Steven N, Na Jie, Boddicker Nicholas, Gnanaolivu Rohan D, Smadbeck James, Ding Li, Billadeau Daniel D, Mayer Aaron T, Majumder Shounak, Morais Lyra Paulo Cilas, Lee Adrian V, Monteiro Alvaro N, Villasboas Jose C, McWilliams Robert, Couch Fergus J

СтатьяПеревод в очереди

Аннотация

PURPOSE: Germline pathogenic variants (PV) in ATM increase the risk of pancreatic ductal adenocarcinoma (PDAC), but the underlying tumor biology of PDAC associated with germline PV in ATM has not been adequately explored.

EXPERIMENTAL

DESIGN

Whole-genome, whole-exome, and RNA sequencing were performed on PDAC tumors from 25 germline ATM PV carriers diagnosed at Mayo Clinic between 2007 and 2017. Somatic and copy-number alterations, mutational signatures, transcriptomic subtypes, and the immune landscape were evaluated.

RESULTS

High-quality whole-exome and whole-genome sequencing were obtained from 21 and 15 tumors, respectively. Biallelic inactivation of ATM was observed in 87%, KRAS PV in 90%, CDKN2A homozygous loss in 60%, and TP53 alterations in <10% of these tumors. A predominant clock-like mutational signature was present in all samples. Whole-transcriptome analysis identified that the aberrantly differentiated endocrine exocrine subtype accounted for 18% of PDAC and was consistently associated with >5-year overall survival. In addition, a 28-gene expression-based signature associated with overall survival was identified and further validated in The Cancer Genome Atlas cohort. Immune landscape analysis through CODEX identified enriched CD4 T-helper cell/tumor interactions and reduced B7H3-high cell/tumor interactions in ATM PV carriers compared with noncarriers.

CONCLUSIONS

The observed absence of TP53 PV and enrichment for CDKN2A alterations in ATM tumors, along with differences in the mutational signatures, transcriptomic subtypes and immune landscape, improve our understanding of the mechanistic pathways involved in PDAC development in germline ATM PV carriers and help identify potential targeted therapeutic strategies.

Для цитирования: Yadav Siddhartha, Bao Riyue, Graham Rondell P, Hu Chunling, Hart Steven N, Na Jie, Boddicker Nicholas, Gnanaolivu Rohan D, Smadbeck James, Ding Li, Billadeau Daniel D, Mayer Aaron T, Majumder Shounak, Morais Lyra Paulo Cilas, Lee Adrian V, Monteiro Alvaro N, Villasboas Jose C, McWilliams Robert, Couch Fergus J. Genomic and Immune Landscape of Pancreatic Ductal Adenocarcinoma Associated with Germline Pathogenic Variants in ATM.. Clinical cancer research : an official journal of the American Association for Cancer Research. 2025. DOI: 10.1158/1078-0432.ccr-24-4120.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.